EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ORYZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.0357
March 31, 2026 -0.0313
December 31, 2025 -0.0404
September 30, 2025 -0.0432
June 30, 2025 -0.0697
March 31, 2025 -0.0701
December 31, 2024 -0.0626
September 30, 2024 -0.0713
June 30, 2024 -0.0698
March 31, 2024 -0.0516
December 31, 2023 -0.0631
September 30, 2023 -0.0738
June 30, 2023 -0.0661
March 31, 2023 -0.0794
December 31, 2022 -0.0825
September 30, 2022 -0.0749
June 30, 2022 -0.0445
Date Value
March 31, 2022 -0.0927
September 30, 2021 -0.0836
June 30, 2021 -0.069
March 31, 2021 -0.0921
December 31, 2020 -0.0785
September 30, 2020 -0.076
June 30, 2020 -0.0808
March 31, 2020 -0.0919
December 31, 2019 -0.0996
September 30, 2019 -0.0989
June 30, 2019 -0.1079
March 31, 2019 -0.0358
December 31, 2018 -0.0378
September 30, 2018 -0.0434
June 30, 2018 -0.0094
March 31, 2018 -0.0656
March 31, 2016 -0.028

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Pharma Mar SA 3.741
Grifols SA 0.7749
ACADIA Pharmaceuticals, Inc. 2.220
Alkermes Plc 0.385
Alnylam Pharmaceuticals, Inc. 5.923